The Effect of Pregabalin Levels on Pain and Substance P Level Post-Cesarean Section

Author:

Gaus Syafruddin,Harahap Muhammad WirawanORCID,Ahmad Muhammad Ramli,Husain Alamsyah Ambo Ala,Wirawan Nur SuryaORCID

Abstract

BACKGROUND: Post-operative pain is a very important problem faced by post-operative patients. Antihyperalgesia is caused by the inhibition of the neurotransmitter glutamate and substance P (SP) by pregabalin. This study aimed to compare the effect of preventive administration of 50 mg oral pregabalin and 1 g paracetamol with 75 mg oral pregabalin and 1 g intravenous paracetamol on Numeric Rating Scale (NRS) scores and SP levels after cesarean section with spinal anesthesia. AIM: The objective of the study was to compare the effect of preventive administration of 50 mg oral pregabalin and 1 g paracetamol with 75 mg oral pregabalin and 1 g intravenous paracetamol on NRS scores and SP levels after cesarean section with spinal anesthesia. METHODS: This study used a double-blind randomized trial design. Samples were selected randomly and consecutively from the entire population that met the inclusion criteria. There were a total of 30 samples. SP levels were measured 2 h before cesarean section. The study drug was administered by mouth with a sip of water 1 h before the expected time of the surgical incision. SP levels were checked at the 4th h (SP 1) and 6th h (SP 2) postoperatively. The assessment of the degree of pain using the NRS was carried out at 2 h, 4 h, 6 h, 12 h, and 24 h postoperatively. This study used the Mann–Whitney U-test to compare both the levels of SP and NRS between the two groups. RESULTS: The results of this study showed that there was a significant difference in the NRS scores between the 50 mg and 75 mg pregabalin groups (p < 0.05). In the 75 mg pregabalin group, the NRS scores were lower than in the 50 mg pregabalin group in patients undergoing CS surgery under spinal anesthesia. There was a significant difference in SP levels between the 50 mg and 75 mg pregabalin groups (p < 0.05). SP levels in the 50 mg pregabalin group increased at 4 h and 6 h postoperatively, while in the 75 mg pregabalin group, it tended to decrease at 4 h and 6 h postoperatively. CONCLUSION: The quiescent and mobile NRS scores in the 75 mg pregabalin group were lower than the 50 mg pregabalin group with a combination of 1 g intravenous paracetamol after SC surgery. SP levels in the 75 mg pregabalin group decreased compared to the 50 mg pregabalin group with a 1 g intravenous paracetamol combination which experienced an increase after CS surgery. Pregabalin 75 mg is recommended for preventive use in CS surgery.

Publisher

Scientific Foundation SPIROSKI

Subject

General Medicine

Reference25 articles.

1. Pogatzki-Zahn EM, Segelcke D, Schug SA. Postoperative pain- from mechanisms to treatment. Pain. 2017;2(2):e558. https:// doi.org/10.1097/PR9.0000000000000588 PMid:29392204

2. Yu M, Zhao LF, Fang L, Lei Y. Clinical analysis of the effect of preemptive analgesia with parecoxib sodium on the corresponding index in cesarean section. J Hainan Med Univ. 2017;23(17):75-8.

3. Lalenoh H, Tanra A, Yusuf I. The antinociceptive effects of pregabalin on post-operative hysterectomy patient. J Anesth Clin Res. 2014;5(11):1-6.

4. Elvidiansyah, Fuadi I, Sitanggang RH.Comparison of the effects of pregabalin 150 mg with a single dose of pregabalin 300 mg on numerical rating scale values and postoperative analgetic needs in abdominal hysterectomy patients. J Anest Periop. 2014;2(2):145-52.

5. Gold MS. Peripheral pain mechanisms and nociceptor sensitization. In: Ballantyne JC, Fisman SM, Rathmell JP, editors Bonica’s management of Pain. 5th ed. Netherlands: Wolters Kluwer; 2019. p. 330-1.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3